1. Introduction {#sec1-molecules-24-04021}
===============

Essential oils (EOs) are complex mixtures derived from various parts of plants with strong aromatic components such as terpenes. They are used in many fields such as medicine, cosmetic, and food industry \[[@B1-molecules-24-04021],[@B2-molecules-24-04021]\]. The available literature reported that EOs possess, among others, significant antiseptic, antibacterial, antiviral, antioxidant, anti-parasitic, antifungal, and insecticidal activities \[[@B3-molecules-24-04021]\].

At the moment, Morocco is considered as one of the principal suppliers and producers of some aromatic plants, such as *Artemisia herba-alba* Asso, *Mentha pulegium* L., *Lavandula stoechas* L., and *Rosmarinus officinalis* L. Moreover, these plants produce very high added value products contributing to the economic development of Morocco \[[@B4-molecules-24-04021]\].

*Artemisia herba-alba*, *chih* in Arabic, belongs to the Asteraceae family; its essential oil is known for its antimicrobial, antioxidant, insecticidal, and antispasmodic activities. It is also used in traditional medicine as an antispasmodic and in treatment of diabetes mellitus \[[@B2-molecules-24-04021],[@B5-molecules-24-04021]\].

*Origanum majorana* L. is a lamiaceous species, known for its antimicrobial, antioxidant, antidiabetic, and antitumoral activities \[[@B6-molecules-24-04021]\]. In traditional medicine, the plant is used as an antiepileptic and a sedative drug \[[@B7-molecules-24-04021]\].

The aim of the present study was to identify the components of *A. herba-alba* and *O. majorana* EOs from Morocco, and to evaluate their antimicrobial activity, against some Gram-positive and Gram-negative bacteria, and their antifungal efficacy.

2. Results {#sec2-molecules-24-04021}
==========

2.1. Essential Oil Yields and Composition {#sec2dot1-molecules-24-04021}
-----------------------------------------

Hydrodistillation of the aerial parts of *A. herba alba* and of *O. majorana* resulted in pale yellow oils in 0.86% and 0.97% yield, on a dry mass basis, respectively. [Table 1](#molecules-24-04021-t001){ref-type="table"} and [Table 2](#molecules-24-04021-t002){ref-type="table"} report the percent composition of the essential oils; compounds are listed according to their elution on a HP-5MS column. Fifty-eight compounds were identified, 14 for *A. herba-alba*, and 44 for *O. majorana*, accounting for 97.6% and 97.8% of the total oil, respectively. In the essential oil from *A. herba-alba cis*-thujone (25.5%), *trans*-thujone (17.7%), vanillyl alcohol (11.5%), and *nor*-davanone (7.8%) are the main components. In the essential oil from *O. majorana,* terpinen-4-ol (34.1%), α-terpinene (19.2%), and terpineol (8.9%) are the main constituents.

2.2. Antimicrobial Activity {#sec2dot2-molecules-24-04021}
---------------------------

The antimicrobial activity of *A. herba-alba* and *O. majorana* essential oils was tested, at different concentrations, against 20 microorganisms, both Gram-positive and Gram-negative strains. [Figure 1](#molecules-24-04021-f001){ref-type="fig"} shows a representative image of the antimicrobial activity. The EO of *A. herba-alba* showed inhibitory effects against 15 bacterial strains, the most sensitive being *Brochothrix thermosphacta* 7R1, *Bacillus clausii* 2226 and *Salmonella* Typhimurium; five strains resulted resistant to this EO: *Hafnia alvei* 53M, *Carnobacterium maltaromaticum* F1201, *Carnobacterium maltaromaticum* D1203, *Enterococcus faecalis* 226 and *Enterococcus faecalis* ES1 ([Table 3](#molecules-24-04021-t003){ref-type="table"}). *O. majorana* essential oil showed a wider spectrum of activity as it was active against all microbial strains tested ([Table 4](#molecules-24-04021-t004){ref-type="table"}).

Data analysis showed for the EO of *A. herba-alba* the same antimicrobial activity of tetracycline against *Streptococcus salivarius*, but higher than gentamicin, and exhibited stronger antimicrobial activity than both antibiotics against *Br. thermosphacta* D274, *B. clausii* 2226, and *S.* Typhimurium and lower antimicrobial activity than that of both antibiotics against *Staphylococcus* sp. GB1, *Staphylococcus saprophyticus* 3S, *Escherichia coli* 32, *Br. thermosphacta* 7R1, *Staphylococcus* sp. ES1, and *Serratia proteamaculans* 20P. On the other hand, the antimicrobial activity of *O. majorana* essential oil was stronger than both antibiotics against *Str. salivarius*, *E. coli* 32, *Br. thermosphacta* 7R1, *H. alvei* 53M, *Salmonella sp*. ES1, *Br. thermosphacta* D274, *B. clausii* 2226, *Ente. faecalis* 226, *S.* Typhimurium, and *Staphylococcus aureus.* The same antimicrobial activity as gentamicin was recorded against *Staph. saprophyticus* 3S, *C. maltaromaticum* H1201, *C. maltaromaticum* F1201, *Ent. faecalis* E21 and lower antimicrobial activity than both antibiotics against *Staph. sp* GB1 and *Listeria innocua* 1770.

2.3. Antifungal Activity {#sec2dot3-molecules-24-04021}
------------------------

[Table 5](#molecules-24-04021-t005){ref-type="table"} reports the inhibition halos in (mm) at the dose of 20 µL of the two essential oils against *Aspergillus niger* isolated from the spoiled butter. This fungal strain was sensitive to both essential oils; the highest inhibitory activity was showed by *A. herba-alba* essential oil against *A. niger.* [Figure 2](#molecules-24-04021-f002){ref-type="fig"} shows the antifungal activity of both EOs as determined in the same agar dish. However, diameters of inhibition halos were measured on two separated agar dishes.

3. Discussion {#sec3-molecules-24-04021}
=============

In our *A. herba-alba* essential oil oxygenated monoterpenes (57.3%) predominated, with *cis*-thujone (25.5%) and *trans*-thujone (17.7%) as the main constituents. Vanillyl alcohol (11.5%) and *nor*-davanone (7.8%) were in appreciable amounts.

These results agree with literature on the essential oil from *A. herba-alba* from different countries that evidenced *cis*- and/or *trans*-thujone as the principal constituents \[[@B8-molecules-24-04021],[@B9-molecules-24-04021],[@B10-molecules-24-04021]\]. On the other hand, other studies showed eucalyptol (32.8%) as the main constituent of the *A. herba-alba* EO from Iran, and caryophyllene acetate (10.75%) for a Jordanian EO \[[@B11-molecules-24-04021],[@B12-molecules-24-04021]\]. These compounds are totally absent in our essential oil. Camphor is reported as principal component in essential oil from Algeria and Tunisia (ranging between 19.6% and 50.5%) \[[@B13-molecules-24-04021],[@B14-molecules-24-04021]\], but it is present in a low percentage in our sample (4.9%).

Moreover, other studies evidenced that davanone is one of the main constituents, with a percent greater than 10% \[[@B15-molecules-24-04021],[@B16-molecules-24-04021]\]. In our EO, davanone and its derivative, *cis, threo*-davanafuran, accounted for 13.6% of the oil. Instead, this is the first report on the presence of vanillyl alcohol as one of the main constituents of this EO. Other studies reported camphor as the major component of the essential oil (17.8%--50.3%) \[[@B13-molecules-24-04021],[@B15-molecules-24-04021],[@B17-molecules-24-04021],[@B18-molecules-24-04021],[@B19-molecules-24-04021]\] that, instead, is absent in our sample or chrysanthenone, present in our EO with its derivative, *iso*-chrysanthenyl acetate \[[@B20-molecules-24-04021],[@B21-molecules-24-04021]\].

Monoterpenes predominated (91.1%) in the oil of *O. majorana*, both hydrocarbons and oxygenated compounds; sesquiterpenes accounted for 6.8%. The main components are terpinen-4-ol (34.1%), α-terpinene (19.2%), and terpineol (8.9%). Our results are in agreement with many studies that reported terpinen-4-ol among the principal constituents of the essential oil of *O. majorana* \[[@B22-molecules-24-04021],[@B23-molecules-24-04021],[@B24-molecules-24-04021],[@B25-molecules-24-04021],[@B26-molecules-24-04021]\]. Moreover, α-terpinene was present in similar percentage (ranging from 11.08% to 12.72%) also in essential oils from Tunisia and Morocco \[[@B22-molecules-24-04021],[@B27-molecules-24-04021]\]. Instead, in the EO from the Venuezelan Andes α-terpinene is reported in lesser percentages (3.6%) \[[@B26-molecules-24-04021]\]. *trans*-Sabinene hydrate was reported as one of the principal components in other studies \[[@B28-molecules-24-04021],[@B29-molecules-24-04021]\], in our sample its isomer was present in a low quantity (1.3%). Linalool, absent in our essential oil, is the main compound in the EO of *O. majorana* from Turkey with a percent of 88.01% \[[@B30-molecules-24-04021]\]. Moreover, 4-terpinene and γ-terpinene were identified as the main components in *O. majorana* from Taiwan and Morocco, respectively \[[@B27-molecules-24-04021],[@B31-molecules-24-04021]\].

Most microorganisms used in this study were sensitive to both essential oils, with the dose of 20 μL of EO sufficient to stop the growth of almost all tested Gram-positive and Gram-negative strains. In particular, *O. majorana* EO resulted more active, showing a wide spectrum of activity. On the other hand, the EO of *A. herba-alba* showed inhibitory effects against 15 bacterial strains.

The available literature reports the antimicrobial activity of *A. herba-alba* essential oil against *Staph. aureus*, *E. coli*, and *B. cereus* \[[@B23-molecules-24-04021],[@B32-molecules-24-04021],[@B33-molecules-24-04021]\]. Moreover, several studies showed a great potential of *A. herba-alba* EO oil as an antibacterial agent against *Klebsiella pneumoniae*, *Listeria monocytogenes*, *Vibrio colerae*, and *S.* Typhimurium \[[@B34-molecules-24-04021],[@B35-molecules-24-04021],[@B36-molecules-24-04021]\]. Our results showed variable antimicrobial and antifungal activity of the essential oil, being the inhibition zones in the range of 10--24 mm. Gram-positive bacteria resulted more sensitive to this EO. The Gram-positive *B. clausii* 2226 was the most sensitive tested strain, with the strongest inhibition zone (24.00 ± 1 mm). *B. clausii* was used as a model of spore-forming aerobic microorganism and our findings showed that our *A. herba-alba* EO is suitable to control the growth of this microorganism. It is well known that spore forming bacteria (also called thermoduric) are the main problem in pasteurized foods, both from the point of view of food spoilage and human intoxication. Gram-negative strains also displayed variable degree of susceptibility to this EO. The maximum activity was showed against the pathogen strain *S.* Typhimurium (17.7 ± 0.6), but *C. maltaromaticum* F1201, *C. maltaromaticum* D1203, *H. alvei* 53M, *Ent. faecalis* E21, and *Ent. faecalis* 226 resulted resistant, since no inhibition zone was observed. Due to the involvement of *S*. Typhimurium in the majority of food intoxication across the world, the antimicrobial capability of this EO could be of pivotal importance in the control of this microorganism in foods.

The antimicrobial activity of *O. majorana* essential oil appears to be similarly effective against both Gram-positive and Gram-negative microorganisms. These results agree with literature data \[[@B21-molecules-24-04021],[@B34-molecules-24-04021],[@B35-molecules-24-04021]\]. Data of previous research showed that *O. majorana* essential oil was active against a large spectrum of different bacteria strains: *E. coli*, *Str. agalactiae*, *Shigella dysenteriae*, *Salmonella* Enteritidis, *Staph. aureus*, *Ent. faecalis*, *E. coli*, and *Klebsiella pneumoniae* \[[@B26-molecules-24-04021],[@B37-molecules-24-04021]\].

In our study, all tested strains were sensitive to this essential oil, with the Gram-positive *S. aureus* the most sensitive with the greatest inhibition zone (32.2 ± 2.5 mm); the more sensitive Gram-negative was *S.* Typhimurium, with an inhibition zone of 29.7 ± 0.6 mm.

The antimicrobial activity of both essential oils could be related to their content in oxygenated monoterpenes, which constitute about 57.3% and 53.0% of the EOs of *A. herba alba* and *O. majorana*, respectively. Similar findings have been already previously reported \[[@B38-molecules-24-04021],[@B39-molecules-24-04021]\].

The major components of *O. majorana* EO, e.g., terpinen-4-ol, α-terpinol and α-pinene, have been reported for their antimicrobial and antifungal properties \[[@B21-molecules-24-04021]\]. Additionally, the main constituents of the EO of *A. herba-alba, cis*- and *trans*-thujone and vanillyl alcohol, have been reported for their antimicrobial, anti-inflammatory, and antioxidant activities \[[@B40-molecules-24-04021],[@B41-molecules-24-04021]\]. Oxygenated monoterpenes exhibit high antimicrobial activity on whole cell and possess antifungal effects. These compounds diffuse into and damage cell membrane structures \[[@B42-molecules-24-04021]\].

Our results showed high antifungal activity for both essential oils, with the highest inhibitory activity shown by the EO of *A. herba-alba* against *Aspergillus niger* (inhibition zone 23.6 ± 1.5 mm). These results are consistent with data previously reported \[[@B29-molecules-24-04021],[@B43-molecules-24-04021]\].

4. Materials and Methods {#sec4-molecules-24-04021}
========================

4.1. Plant Material {#sec4dot1-molecules-24-04021}
-------------------

The aerial parts of *A. herba-alba* and *O. majorana* were collected in the Azzemour region, South West Morocco, in June 2018, in flowering stage, and dried in the shade. The plants were identified by Prof. V. De Feo. A voucher specimen of each plant is stored in Department of Agricultural Sciences, University of Naples Federico II.

4.2. Essential Oil Extraction {#sec4dot2-molecules-24-04021}
-----------------------------

One kilogram of *A. herba-alba* and *O. majorana* aerial parts was subjected to hydrodistillation for 3 h, according to the standard procedure described in the European Pharmacopoeia \[[@B44-molecules-24-04021]\]. The oils were solubilized in *n*-hexane, filtered over anhydrous sodium sulphate and stored under N~2~ at +4 °C in the dark, until tested and analyzed.

4.3. GC-FID Analysis {#sec4dot3-molecules-24-04021}
--------------------

Analytical gas chromatography was carried out on a Perkin-Elmer Sigma-115 gas-chromatograph (Perkin Elmer, Waltham, MA, USA) equipped with an FID and a data handling processor. The separation was achieved using a HP-5 MS fused-silica capillary column (30 m × 0.25 mm i.d., 0.25 µm film thickness). Column temperature: 40 °C, with 5 min initial hold, and then to 270 °C at 2 °C/min, 270 °C (20 min); injection mode splitless (1 µL of a 1:1000 *n*-hexane solution). Injector and detector temperatures were 250 °C and 290 °C, respectively. Analysis was also run by using a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm i.d., 0.25 µm film thickness). In both cases, helium was used as carrier gas (1.0 mL/min).

4.4. GC/MS Analysis {#sec4dot4-molecules-24-04021}
-------------------

Analysis was performed on an Agilent 6850 Ser. II apparatus (Agilent, Roma, Italy), fitted with a fused silica DB-5 capillary column (30 m × 0.25 mm i.d., 0.33 µm film thickness), coupled to an Agilent Mass Selective Detector MSD 5973 (Agilent); ionization energy voltage 70 eV; electron multiplier voltage energy 2000 V. Mass spectra were scanned in the range 40--500 amu, scan time 5 scans/s. Gas chromatographic conditions were as reported in the previous paragraph; transfer line temperature, 295 °C.

4.5. Identification of the Essential Oil Components {#sec4dot5-molecules-24-04021}
---------------------------------------------------

Most constituents were identified by comparison of their Kovats retention indices (Ri) (determined relative to the tR of *n*-alkanes (C10--C35), with either those of the literature \[[@B45-molecules-24-04021],[@B46-molecules-24-04021],[@B47-molecules-24-04021]\] and mass spectra on both columns or those of authentic compounds available in our laboratories by means of NIST 02 and Wiley 275 libraries \[[@B48-molecules-24-04021]\]. The components relative concentrations were obtained by peak area normalization.

4.6. Antibacterial Assay {#sec4dot6-molecules-24-04021}
------------------------

The antibacterial activity was evaluated in vitro, by means of the agar diffusion test on the plate. The activity of the essential oils was tested on the 20 microorganisms reported in [Table 6](#molecules-24-04021-t006){ref-type="table"}. All of them belong to the collection of the Department of Agricultural Sciences, University of Naples Federico II.

Microbial strains were previously grown in TSB tryptone soya broth for 24 h. A volume of 0.1 mL of the microbial suspensions (about 1 × 10^8^ CFU/mL) was uniformly distributed on Nutrient agar plates in sterile conditions. Different amounts of essential oils were spotted on the inoculated plates: 50, 40, 20, 15, 10, and 5 µL for *O. majorana* and 20, 15, 10, and 5 µL for *A. herba-alba* essential oils. After 10 min, under sterile conditions, plates were then incubated at optimal growth condition culture of each strain. The antimicrobial activity was evidenced by measuring the diameter (in mm) of the zone of inhibition. Ethanol was used as the negative control; tetracycline (10 µg) and gentamycin (10 µg) were used as positive controls. Each experiment was carried out in three independent replicates and result is the average with standard deviation.

4.7. Antifungal Activity {#sec4dot7-molecules-24-04021}
------------------------

The antifungal activity was evaluated in vitro, using the agar well diffusion method on the plates. The activity was tested against *Aspergillus niger* isolated from a spoiled butter sample and identified by phenotypic characteristics. The fungus was previously grown in TSA agar plates at 28 °C until spore formation. Then, 1 mL of a spore suspension in quarter strength Ringer solution, containing about 1 × 10^8^ spores per mL, was uniformly distributed on Nutrient agar plates in sterile conditions, then a hole was punched with sterile cork and 20 µL of each EO was introduced into the well; the plates were incubated at 28 °C for 4--5 days. Ethanol was used as the negative control. The antifungal activity was evaluated by measuring diameter of the inhibition area. Each experiment was carried out in three independent replicates and result is the average with standard deviation.

4.8. Statistical Analysis {#sec4dot8-molecules-24-04021}
-------------------------

Data of each experiment were statistically analyzed using GraphPad Prism 6.0 software (GraphPad Software Inc., San Diego, CA, USA), followed by comparison of means (one-way ANOVA) using Dunnett's multiple comparisons test, at the significance level of *p* \< 0.05.

5. Conclusions {#sec5-molecules-24-04021}
==============

The composition of *Artemisia herba-alba* and *Origanum majorana* essential oils growing in Morocco was analyzed and its antibacterial and antifungal activity investigated. The results indicated an important antimicrobial activity against different microorganisms especially from *O. majorana* essential oil. Thus, they can maybe be applied in food industry as natural preservatives, due to their antibacterial properties. Further organoleptic features and toxicological studies are required to prove the safety of the oils.

**Sample Availability:** Samples of *A. herba-alba* and *O. majorana* essential oils are available from the authors.
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![Representative antimicrobial activity of (**A**) *Origanum majorana* essential oil against *Brochothrix thermosphacta* D274 at the dose of 50, 40, 20, and 15 µL (from 1 to 4, respectively) and (**B**) *Artemisia herba-alba* essential oil against *Bacillus clausii* 2226 at the concentrations of 20, 15, 10, and 5 µL (from 1 to 4, respectively).](molecules-24-04021-g001){#molecules-24-04021-f001}

![Antifungal activity of *A. herba-alba* (1) and *O. majorana* (2) essential oils against *Aspergillus niger* at the dose of 20 µL.](molecules-24-04021-g002){#molecules-24-04021-f002}

molecules-24-04021-t001_Table 1

###### 

Chemical composition of *Artemisia herba-alba* essential oil.

  Compound                     \%     Ki ^a^   Ki ^b^   Identification ^c^
  ---------------------------- ------ -------- -------- --------------------
  *trans*-Arbusculone          4.5    1048              1,2
  *cis*-Thujone                25.5   1079     1102     1,2,3
  *trans*-Thujone              17.7   1111     1114     1,2,3
  Camphor                      4.9    1150     1146     1,2,3
  *nor*-Davanone               7.8    1200     1231     1,2
  *cis*-Chrysanthenylacetate   4.7    1231     1265     1,2
  Undec-10-en-1-al             1.3    1261     1296     1,2
  Cyclosativene                T      1342     1368     1,2
  *cis, threo*-Davanafuran     5.8    1386     1415     1,2
  Vanillyl Alcohol             11.5   1424     1447     1,2
  *n*-Dodecanol                3.1    1445     1470     1,2
  Isobornyl *n*-butyrate       4.9    1466     1491     1,2
  \<E\>-Jasmolactone           3.4    1483     1491     1,2
  Artedouglasia Oxide C        2.5    1496     1523     1,2
  Total                        97.6                     
  Oxygenated monoterpene       56.4                     
  Oxygenated sesquiterpenes    2.5                      
  Other compounds              38.7                     

^a^ Kovats retention index on HP-5 MS column; ^b^ Kovats retention index on HP Innovax column; ^c^ Identification: 1 = Kovats retention index, 2 = mass spectrum, 3 = co-injection with pure compound; T = traces, less than 0.05%.

molecules-24-04021-t002_Table 2

###### 

Chemical composition of *Origanum majorana* essential oil.

  Compound                     \%     KI ^a^   KI ^b^   Identification ^c^
  ---------------------------- ------ -------- -------- --------------------
  α-Pinene                     4.1    941      932      1,2,3
  p-Cymene                     2.6    950      1024     1,2,3
  *iso*-Sylvestrene            0.6    952      1008     1,2,3
  β-Pinene                     0.2    975      974      1,2,3
  α-Phellandrene               2.6    984      1002     1,2,3
  δ-3-Carene                   1.9    1008     1011     1,2
  α-Terpinene                  19.2   1021     1017     1,2,3
  Limonene                     0.1    1038     1029     1,2,3
  1,8 Cineole                  3.0    1047     1031     1,2,3
  β-Ocimene                    0.1    1061     1037     1,2,3
  *cis*-Sabinene hydrate       1.3    1070     1070     1,2
  Terpinen-4-ol                34.1   1096     1149     1,2,3
  *endo*-Fenchyl-acetate       9.8    1114     1220     1,2
  Pulegone                     0.7    1122     1237     1,2
  *trans*-Pinocarveol          0.3    1143     1139     1,2
  Terpineol                    8.9    1160     1133     1,2,3
  *cis*-Limonene oxide         T      1188     1136     1,2
  dihydro-Linalool             0.1    1191     1135     1,2
  *cis*-Verbenol               T      1193     1141     1,2,3
  Viridene                     0.1    1199     1167     1,2
  (E)-Isocitral                0.2    1205     1180     1,2
  Thymol                       0.2    1211     1290     1,2,3
  Carvacrol                    0.3    1220     1299     1,2,3
  γ-Elemene                    0.1    1233     1338     1,2,3
  α-Terpinyl acetate           0.8    1242     1349     1,2
  Eugenol                      T      1271     1359     1,2,3
  Neryl acetate                0.2    1274     1361     1,2
  α-Copaene                    T      1278     1376     1,2,3
  Geranyl acetate              0.3    1293     1381     1,2,3
  *iso*-Longifolene            0.1    1303     1390     1,2
  (E)-Caryophillene            2.1    1314     1407     1,2,3
  β-Duprezianene               T      1321     1422     1,2
  β-Cedrene                    T      1324     1420     1,2,3
  β-Copaene                    T      1327     1432     1,2,3
  α-Guaiene                    0.2    1332     1439     1,2,3
  Aromadendrene                0.3    1336     1441     1,2,3
  *allo*-Aromadendrene         1.3    1370     1460     1,2
  Valencene                    0.2    1401     1496     1,2,3
  Caryophyllene oxide          T      1436     1583     1,2,3
  Epiglobulol                  T      1445     1590     1,2
  (-)-Spathulenol              T      1453     1578     1,2
  β-Atlanthol                  1.6    1464     1608     1,2,3
  Rosifoliol                   0.1    1485     1600     1,2
  Cubenol                      T      1497     1646     1,2
  Total                        97.8                     
  Monoterpene hydrocarbons     33.1                     
  Oxygenated monoterpene       57.9                     
  Sesquiterpene hydrocarbons   5.1                      
  Oxygenated sesquiterpenes    1.7                      

^a^ Kovats retention index on HP-5 MS column; ^b^ Kovats retention index on HP Innovax column; ^c^ Identification: 1 = Kovats retention index, 2 = mass spectrum, 3 = co-injection with pure compound. T = traces, less than 0.05%.

molecules-24-04021-t003_Table 3

###### 

Antibacterial activity of the essential oil of *A. herba-alba*.

  Strain                       Control      Essential Oil                                                      
  ---------------------------- ------------ --------------- ------------ ------------------ ------------------ ------------------
                               Gentamicin   Tetracyclin     5 μL         10 μL              15 μL              20 μL
  *B. clausii 2226*            11.0 ± 1.0   16.3 ± 1.5      10.3 ± 0.6   14.7 ± 0.6         19.7 ± 1.5 ^a,D^   24.0 ± 1.0 ^a,A^
  *Br. thermosphacta* 7R1      18.3 ± 1.5   19.3 ± 1.2      na           6.0 ± 0.0          6.0 ± 0.1          12.3 ± 0.6
  *Br. thermosphacta* D274     6.0 ± 0.0    8.7 ± 1.2       6.0 ± 0.0    11.7 ± 0.6 ^a,C^   14.7 ± 0.6 ^a,A^   17.7 ± 0.6 ^a,A^
  *C. maltaromaticum* 9P       6.0 ± 0.0    24.3 ± 1.2      6.0 ± 0.0    9.0 ± 1.0 ^b^      11.7 ± 0.6 ^a^     12.3 ± 0.6 ^a^
  *C. maltaromaticum* D1203    6.0 ± 0.0    22.3 ± 0.6      na           na                 na                 na
  *C. maltaromaticum* F1201    6.0 ± 0.0    23.3 ± 1.5      na           na                 na                 na
  *C. maltaromaticum* H1201    10.0 ± 0.0   na              na           na                 na                 6.0 ± 0.0 ^A^
  *E. coli* 32                 14.7 ± 0.6   18.7 ± 1.2      na           na                 6.0 ± 0.0          6.0 ± 0.0
  *Ent. faecalis* 226          6.0 ± 0.0    9.0 ± 1.0       na           na                 na                 na
  *Ent. faecalis* E21          6.0 ± 0.0    14.7 ± 0.6      na           na                 na                 na
  *H. alvei* 53M               11.7 ± 1.5   9.7 ± 0.6       na           na                 na                 na
  *L. innocua* 1770            25.3 ± 0.6   20.3 ± 1.5      na           na                 na                 6.0 ± 0.0
  *P. fragi* 6P2               14.7 ± 0.6   17.0 ± 1.0      na           6.0 ± 0.0          9.3 ± 0.6          13.3 ± 2.1
  *Staph. aureus*              6.0 ± 0.0    15.3 ± 0.6      na           na                 na                 6.0 ± 0.0
  *S.* Typhimurium             9.7 ± 0.6    12.7 ± 1.2      na           6.0 ± 0.0          14.0 ± 1.7 ^b^     17.7 ± 0.6 ^a,B^
  *Serr. proteamaculans* 20P   12.3 ± 0.6   24.3 ± 1.2      na           6.0 ± 0.0          7.7 ± 0.6          10.3 ± 0.6
  *Str. salivarius*            6.0 ± 0.0    18.7 ± 1.2      na           6.0 ± 0.0          14.0 ± 1.0 ^a^     18.3 ± 1.5 ^a^
  *Staph. saprophyticus* 3S    24.0 ± 1.0   29.0 ± 3.6      na           na                 6.0 ± 0.0          6.0 ± 0.0
  *Staph. sp.*ES1              19.3 ± 1.2   29.3 ± 1.2      na           6.0 ± 0.0          8.3 ± 0.6          10.3 ± 0.6
  *Staph.sp.*GB1               21.3 ± 1.2   27.7 ± 2.5      6 ± 0.0      11.3 ± 1.2         14.7 ± 0.6         17 ± 1.0

Data represent the diameter inhibition (in mm). Results are the mean of three repetitions ± standard deviation (SD) of the inhibition zone. na = not active. Dunnett's test vs. Gentamicin (^a,b,c,d^) or Tetracycline (^A,B,C,D^): ^a,A^ *p* \< 0.0001; ^b,B^ *p* \< 0.001; ^c,C^ *p* \< 0.01; ^d,D^ *p* \< 0.05. *B.: Bacillus*; *Br.: Brochothrix*; *C.: Carnobacterium*; *E.: Enterococcus*; *Staph.: Staphylococcus*; *L.: Listeria*; *E.: Escherichia*; *H.: Hafnia*; *P.: Pseudomonas*; *S.: Salmonella; Serr.: Serratia*; *Str.: Streptococcus*.
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###### 

Activity of the essential oil of *O. majorana*.

  Strain                        Control      Essential Oil                                                                                              
  ----------------------------- ------------ --------------- ---------------- ---------------- ------------------ ------------------ ------------------ ------------------
                                Gentamicin   Tetracyclin     5 µL             10 µL            15 µL              20 µL              40 µL              50 µL
  *B. clausii* 2226             11.0 ± 1.0   16.3 ± 1.5      na               6.0 ± 0.0        15.3 ± 0.6^b^      23.3 ± 1.5 ^a,B^   24.7 ± 0.6 ^a,B^   28.3 ± 1.5 ^a,B^
  *Br. thermosphacta* D274      6.0 ± 0.0    8.7 ± 1.2       10.6 ± 0.6^d^    13.3 ± 1.2 ^a^   18.3 ± 0.6 ^a,B^   23.0 ± 1.7 ^a,B^   24.3 ± 1.2 ^a,B^   26.3 ± 1.2 ^a,B^
  *Br. thermosphacta* 7R1       18.3 ± 1.5   19.3 ± 1.2      11.3 ± 1.2       15.3 ± 0.6       18.0 ± 0.0         20.3 ± 0.6^\*^     20.0 ± 0.0         21.3 ± 0.6^c,D^
  *C. maltaromaticum* 9P        6.0 ± 0.0    24.3 ± 1.2      na               na               na                 6.0 ± 0.0          6.0 ± 0.0          9.3 ± 0.6^a^
  *C.maltaromaticum* H~1~201    10.0 ± 0.0   na              6.0 ± 0.0^A^     6.0 ± 0.0 ^A^    8.7 ± 1.2 ^A^      9.7 ± 0.6 ^A^      9.3 ± 0.6 ^A^      9.7 ± 0.6 ^A^
  *C. maltaromaticum* D~1~203   6.0 ± 0.0    22.3 ± 0.6      na               na               na                 6.0 ± 0.0          9.3 ± 0.6 ^a^      13.3 ± 1.5 ^a^
  *C. maltaromaticum* F~1~201   6.0 ± 0.0    23.3 ± 1.5      na               na               na                 6.0 ± 0.0          6.0 ± 0.0          6.0 ± 0.0
  *E. coli* 32                  14.7 ± 0.6   18.7 ± 1.2      9.7 ± 0.6        10.7 ± 1.2       17.7 ± 0.6         20.0 ± 0.0 ^a^     24.3 ± 1.2 ^a,B^   26.7 ± 0.6 ^a,B^
  *Ent. faecalis* 226           6.0 ± 0.0    9.0 ± 1.0       na               na               na                 6.0 ± 0.0          6.0 ± 0.1          9.7 ± 0.7
  *Ent. faecalis* E21           6.0 ± 0.0    14.7 ± 0.6      na               na               na                 6.0 ± 0.0          6.0 ± 0.0          6.0 ± 0.0
  *H. alvei* 53M                11.7 ± 1.5   9.7 ± 0.6       8.3 ± 0.6        10.3 ± 0.6       11.7 ± 0.6 ^C^     12.7 ± 0.6 ^A^     15.0 ± 0.0 ^b,A^   20.3 ± 0.6 ^a,B^
  *L. innocua* 1770             25.3 ± 0.6   20.3 ± 1.5      na               6.0 ± 0.0        9.3 ± 0.6          11.7 ± 0.6         12.3 ± 0.6         13.7 ± 1.5
  *P. fragi* 6P2                14.7 ± 0.6   17.0 ± 1.0      na               na               6.0 ± 0.0          6.0 ± 0.0          6.0 ± 0.0          9.3 ± 0.6
  *Staph. aureus*               6.0 ± 0.0    15.3 ± 0.6      10.7 ± 0.6 ^d^   11.7 ± 1.5 ^c^   16.3 ± 1.5 ^a^     24.3 ± 2.1 ^a,B^   27.7 ± 0.6 ^a,B^   32.3 ± 2.5 ^a,B^
  *S.* Typhimurium              9.7 ± 0.6    12.7 ± 1.2      7.7 ± 2.1        11.7 ± 0.6       14.0 ± 1.7 ^d^     17.3 ± 1.2 ^c,D^   23.3 ± 2.9 ^a,B^   29.7 ± 0.6 ^a,B^
  *Serr.proteamaculans* 20P     12.3 ± 0.6   24.3 ± 1.2      na               na               na                 6.0 ± 0.0          16.3 ± 1.5^a^      19.3 ± 1.2^a^
  *Str. salivarius*             6.0 ± 0.0    18.7 ± 1.2      9.7 ± 0.6 ^c^    11.3 ± 0.6 ^a^   13.0 ± 1.0 ^a^     19.3 ± 1.2 ^a^     20.7 ± 1.2 ^a^     24.3 ± 1.2 ^a,B^
  *Staph. saprophyticus* 3S     24.0 ± 1.0   29.0 ± 3.6      9.9 ± 1.0        11.7 ± 0.6       19.3 ± 1.2         20.3 ± 0.6         21.0 ± 1.0         24.3 ± 1.2
  *Staph.sp.* ES1               19.3 ± 1.2   29.3 ± 1.2      6.0 ± 0.0        6.0 ± 0.0        14.7 ± 7.6         18.7 ± 1.2         20.0 ± 0.0         21.0 ± 1.0
  *Staph.sp.*GB1                21.3 ± 1.2   27.7 ± 2.5      na               na               5.7 ± 0.6          10 ± 0.0           14.7 ± 0.6         19.3 ± 1.2

Data represent the diameter inhibition(in mm). Results are the mean of three repetitions ± standard deviation (SD) of the inhibition zone. na = not active. Dunnett's test vs. Gentamicin (^a,b,c,d^) or Tetracycline (^A,B,C,D^): ^a,A^ *p* \< 0.0001; ^b,B^ *p* \< 0.001; ^c,C^ *p* \< 0.01; ^d,D^ *p* \< 0.05. *B.: Bacillus*; *Br.: Brochothrix*; *C.: Carnobacterium*; *E.: Enterococcus*; *Staph.: Staphylococcus*; *L.: Listeria*; *E.: Escherichia*; *H.: Hafnia*; *P.: Pseudomonas*; *S.: Salmonella; Serr.: Serratia*; *Str.: Streptococcus*.
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###### 

Antifungal activity of *A. herba-alba* and *O. majorana* essential oils.

                           *Aspergillus niger*
  ------------------------ ---------------------
  *Artemisia herba-alba*   23.6 ± 1.5
  *Origanum majorana*      14.0 ± 1.0

Data represent the diameter inhibition (in mm). Results are the mean of three repetitions ± standard deviation (SD) of the inhibition zone.
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###### 

Source and optimal growth conditions of microorganisms.

  Gram                        Microorganism       Source             Growth Conditions
  --------------------------- ------------------- ------------------ -------------------
  **Positive**                *B. clausii* 2226   Supplement         TSB 24h at 30 °C
  *Br. thermosphacta* 7R1     Meat                TSB 24h at 20 °C   
  *Br. thermosphacta* D274    Meat                TSB 24h at 20 °C   
  *C. maltaromaticum* 9P      Meat                TSB 24h at 20 °C   
  *C. maltaromaticum* D1203   Meat                TSB 24h at 25 °C   
  *C. maltaromaticum* F1201   Meat                TSB 24h at 25 °C   
  *C. maltaromaticum* H1201   Meat                TSB 24h at 25 °C   
  *Ent. faecalis* 226         Milk                TSB 24h at 30 °C   
  *Ent. faecalis* E21         Milk                TSB 24h at 30 °C   
  *Staph. aureus*             Meat                TSB 24h at 37 °C   
  *Staph. saprophyticus* 3S   Fermented meat      TSB 24h at 37 °C   
  *Staph.* sp. ES1            Fermented meat      TSB 24h at 37 °C   
  *Staph.* sp. GB1            Fermented meat      TSB 24h at 37 °C   
  *L. innocua* 1770           Milk                TSB 24h at 30 °C   
  *E. coli* 32                Meat                TSB 24h at 37 °C   
  *Str. salivarius*           Milk                TSB 24h at 30 °C   
  **Negative**                *H.alvei* 53M       Meat               TSB 24h at 30 °C
  *Pseud. fragi* 6P2          Meat                TSB 24h at 20 °C   
  *S.* Typhimurium            Chicken meat        TSB 24h at 30 °C   
  *Serr.proteamaculans*20P    Meat                TSB 24h at 25 °C   

*B.: Bacillus; Br.: Brochothrix; C.: Carnobacterium; E.: Enterococcus; Staph.: Staphylococcus; L.: Listeria; E.: Escherichia; H.: Hafnia; P.: Pseudomonas; S.: Salmonella; Serr.: Serratia; Str.: Streptococcus.*
